Results 91 to 100 of about 58,426 (305)

Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis

Journal of Diabetes Investigation, EarlyView.
Our study provides genetic analysis supporting the beneficial effects of GLP1 action on MASLD. These benefits may be attributed to mechanisms such as lowering blood glucose levels, reducing blood pressure, and improving HDL cholesterol levels. ABSTRACT Purpose Previous studies have shown that glucagon‐like peptide 1 (GLP1) receptor agonists may help ...
Zhiqiang Ma, Binyu Wang, Danpei Li, Xi Chen   +3 more
wiley   +1 more source

Hemobilia due to cystic artery pseudoaneurysm: A rare late complication of laparoscopic cholecystectomy [PDF]

, 2017
We discuss a patient with late presentation of hemobilia following cholecystectomy, which is unusual because pseudoaneurysm caused by vascular injury during surgery typically presents soon after surgery.
Badillo, Ricardo, Darcy, Michael D, Kushnir, Vladimir M   +2 more
core   +2 more sources

Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut‐Brain Interaction in Obesity Before and After Treatment

Neurogastroenterology &Motility, EarlyView.
DGBI symptoms are common in obesity and have the potential to exacerbate negative health outcomes. In general, the prevalence of DGBI symptoms decreases after obesity treatment, but patients can also shift from one GI symptom profile to another. ABSTRACT Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes.
Esther Colomier, Janita Halminen, Malin Björck, Gudrún Höskuldsdóttir, Karin Mossberg, My Engström, Björn Eliasson, Ville Wallenius, Lars Fändriks, Jan Tack, Hans Törnblom, Magnus Simrén   +11 more
wiley   +1 more source

Association of fatty acid composition of blood serum with bile lipid composition in cholelithiasis patients

Терапевтический архив, 2008
Aim. To examine correlations between bile lipid composition and fatty acid composition of blood serum in cholelithiasis patients. Material and methods.
V V Tsukanov, E Iu Kupershteĭn, Iu L Tonkikh, E P Bronnikova   +3 more
doaj  

Dietary patterns, genetic predisposition, and risk of cholelithiasis: a large-scale prospective cohort study

Frontiers in Nutrition
BackgroundLimited epidemiological evidence exists concerning the impact of healthy dietary patterns on reducing the risk of cholelithiasis. We aimed to examine the association of seven established dietary patterns with subsequent cholelithiasis risk and ...
Kecheng Jin, Kecheng Jin, Ningning Mi, Ningning Mi, Wangping He, Wangping He, Ruyang Zhong, Ruyang Zhong, Boru Jin, Boru Jin, Zhen Liu, Zhen Liu, Chunlu Dong, Chunlu Dong, Yanyan Lin, Yanyan Lin, Ping Yue, Ping Yue, Bin Xia, Qiangsheng He, Jinqiu Yuan, Wenbo Meng, Wenbo Meng   +22 more
doaj   +1 more source

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Obesity Reviews, EarlyView.
ABSTRACT Tirzepatide has positive effects on weight loss in individuals with overweight or obesity. Considering its broad side‐effect profile, its efficacy and safety in individuals without diabetes mellitus (DM) are yet to be fully understood. To address this, we conducted a comprehensive meta‐analysis of six randomized trials on individuals with ...
Sharath Kommu, Param P. Sharma, Rachel M. Gabor   +2 more
wiley   +1 more source

Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism [PDF]

, 2017
BACKGROUND: Long‐term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel somatostatin analogue, decreases serum insulin‐like growth factor 1 (IGF‐1) and improves insulin sensitivity in cats with HS when ...
Abraham, Berg, Bruns, Church, Colao, Colao, Combes, Cozzi, Dowling, Dunning, Feelders, Freda, Gadelha, Henry, Hofland, Hubina, Hussaini, Jaffe, Katznelson, Kurosaki, Lamb, Laron, Ma, Meij, Meij, Myers, Niessen, Niessen, Niessen, Patel, Petersenn, Peterson, Reubi, Reusch, Reusch, Sathyapalan, Schaefer, Scudder, Shanik, Slingerland, Slingerland, Theodoropoulou, Tyson, Zambre   +43 more
core   +2 more sources

The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies

Obesity Reviews, EarlyView.
ABSTRACT Obesity is a chronic metabolic disease characterized by disturbances in energy homeostasis, leading to excessive fat accumulation. The pathogenesis of the disease is shaped by a complex interplay of genetic, epigenetic, biological, psychological, and environmental factors.
Gašper Tonin, Stjepan Eržen, Zala Mlinarič, Dubravka Jurišić Eržen, Simon Horvat, Tanja Kunej, Jasna Klen   +6 more
wiley   +1 more source

Modified dietary fat intake for treatment of gallstone disease [PDF]

, 2017
Madden AM, Trivedi D, Smeeton NC, Culkin A., 'Modified dietary fat intake for treatment of gallstone disease', Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No.: CD012608, DOI: 10.1002/14651858.CD012608.
Culkin, Alison, Madden, Angela, Smeeton, Nigel, Trivedi, Daksha   +3 more
core   +2 more sources

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

Nutrition in Clinical Practice, Volume 40, Issue 4, Page 816-828, August 2025.
Abstract Cystic fibrosis transmembrane regulator (CFTR)–directed therapies, such as modulators, have transformed the medical management of people with CF, resulting in better lung function, weight, and body mass index in recent years. With improved nutrition status in people on CFTR modulators, the emphasis on a high‐energy, high‐fat diet (the legacy ...
Kay Vavrina, Tara B. Griffin, Angel M. Jones, Terri Schindler, Trang N. Bui, Senthilkumar Sankararaman   +5 more
wiley   +1 more source